Mark Reid is the Director of BioDesk and Regulatory Affairs at Clinical Network Services (CNS) Pty Ltd and has a broad background in Regulatory Affairs with his main area of interest being anti-infective drugs and vaccines. Mark is a virologist by training and has worked on nine anti-infective drug programmes and 12 vaccine programmes including genetically modified organism (GMO) vaccines. One vaccine is now registered in Australia, India and Thailand. Prior to working in the pharmaceutical industry, Mark setup a virological laboratory under ISO 17025 (1999) and ISO 9001. Mark has a BSc (hons), MMedSci (drug dev) and MBA. Mark is also a certified member (by examination) of the Regulatory Affairs Professionals Society for both European and US filings. Mark Reid is the Director of BioDesk and Regulatory Affairs at Clinical Network Services (CNS) Pty Ltd and has a broad background in Regulatory Affairs with his main area of interest being anti-infective drugs and vaccines. Mark is a virologist by training and has worked on nine anti-infective drug programmes and 12 vaccine programmes including genetically modified organism (GMO) vaccines. One vaccine is now registered in Australia, India and Thailand. Prior to working in the pharmaceutical industry, Mark setup a virological laboratory under ISO 17025 (1999) and ISO 9001. Mark has a BSc (hons), MMedSci (drug dev) and MBA. Mark is also a certified member (by examination) of the Regulatory Affairs Professionals Society for both European and US filings.

Vaccines, Immunology